Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Running, not enrolling · Phase 3

Conditions studied: Brain and Central Nervous System Tumors, Neurotoxicity

In brief

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether radiation therapy is more effective when given together with or without temozolomide in treating patients with low-grade glioma. PURPOSE: This randomized phase III trial is studying radiation therapy so see how well it works when given together with or without temozolomide in treating patients with low-grade glioma.

Key facts

Study ID
NCT00978458
Run by
Eastern Cooperative Oncology Group
People needed
540
Starts
2009-11-17
Expected to finish
2026-12-31
Last updated by the study team
2025-09-08

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.